Back
Sage Therapeutics Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
43
SAGE
Sage Therapeutics
Last Price:
$7.39
Seasonality Move:
7.04%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and SAGE is experiencing slight buying pressure.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.96 | Buy |
20-day SMA: | 7.68 | Sell |
50-day SMA: | 7.48 | Sell |
200-day SMA: | 7.6 | Sell |
8-day EMA: | 7.17 | Buy |
20-day EMA: | 7.41 | Sell |
50-day EMA: | 7.36 | Buy |
200-day EMA: | 8.98 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 49.13 | Sell |
Chaikin Money Flow: | 377139 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.09 - 8.29) | Sell |
Bollinger Bands (100): | (5.66 - 7.72) | Buy |
Sage Therapeutics Technical Analysis
Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 7.40 while SAGE 8-day simple moving average is 6.96, which is a Buy signal.
-
The stock price of SAGE is 7.40 while Sage Therapeutics 20-day SMA is 7.68, which makes it a Sell.
-
Sage Therapeutics 50-day simple moving average is 7.48 while SAGE share price is 7.40, making it a Sell technically.
-
SAGE stock price is 7.40 and Sage Therapeutics 200-day simple moving average is 7.60, creating a Sell signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
43
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a SellThe current Sage Therapeutics [SAGE] share price is $7.40. The Score for SAGE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
455M
Price in USD:
7.40
Share Volume:
829.7K
Sage Therapeutics 52-Week Range
52-Week High:
15.74
52-Week Low:
4.62
Sell
43
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?The Sage Therapeutics stock price is 7.40 USD today.
-
Will SAGE stock go up or go down?Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sage Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 7.40 while SAGE 8-day exponential moving average is 7.17, which is a Buy signal.
-
The stock price of SAGE is 7.40 while Sage Therapeutics 20-day EMA is 7.41, which makes it a Sell.
-
Sage Therapeutics 50-day exponential moving average is 7.36 while SAGE share price is 7.40, making it a Buy technically.
-
SAGE stock price is 7.40 and Sage Therapeutics 200-day simple moving average is 8.98, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.41 per share, an increase this year of $2.68 per share, and an increase next year of $1.19 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
-
SAGE Moving Average Covergence Divergence (MACD) indicator is -0.17, suggesting Sage Therapeutics is a Sell
-
Sage Therapeutics Relative Strength Index (RSI) is 49.13, which suggest Sage Therapeutics is oversold
-
The Bollinger Bands (25) for Sage Therapeutics is (7.09 - 8.29), which suggest Sage Therapeutics is a Buy
-
The Bollinger Bands (100) for Sage Therapeutics is (5.66 - 7.72), which suggest Sage Therapeutics is a Buy
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.